Drug intelligence / Profile preview

tetradecylthioacetic acid

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral
01

Overview

Tetradecylthioacetic acid (TTA) is a synthetic 3-thia fatty acid analogue that functions as a pan-agonist of Peroxisome Proliferator-Activated Receptors (PPARs). It exhibits pronounced selectivity for PPARα, and also activates PPARδ (beta/delta) and, to a lesser extent, PPARγ. This chemical modification prevents TTA from undergoing complete β-oxidation, enhancing its biological activity. TTA modulates lipid and fatty acid metabolism by transcriptionally regulating genes involved in fatty acid uptake, transport, and mitochondrial β-oxidation. This action leads to reduced plasma lipids and anti-inflammatory effects. TTA has been investigated for its potential in metabolic disorders such as dyslipidemia, obesity, insulin resistance, type 2 diabetes, and inflammatory conditions. It is also marketed as a nutritional supplement.

Other names
1-(Carboxymethylthio)tetradecane
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)PPARD (Peroxisome proliferator–activated receptor delta)

Beyond the preview

Go deeper on tetradecylthioacetic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tetradecylthioacetic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call